Ependent variable; model (n = 2118), sum R = 0.350, sum R2 = 0.123; two Biomarkers adjusted for cholesterol (mol/mmol) all measured biomarkers which includes cholesterol had been assessed as covariates within the initial model (n = 2118), have been assessed in the initial model (n = 1993); sum R = 0.348, sum R2 = 0.121. Regression coefficient B sum R = 0.350, sum R2 = 0.123; two represents larger (+)/lower (-) Biomarkers adjusted for cholesterol ( ol/mmol) have been assessed in the initial age (years) with each and every unit (mol/L or mol/mmol) enhance in model (n = 1993); sum R = 0.348, sum R2 = 0.121. Regression coefficient B represents greater (+)/lower (-) age respective compounds, e.g., per 1 mol/L improve in lycopene, imply age was six.six years decrease (-6.638 (years) with every single unit ( ol/L or ol/mmol) enhance in respective compounds, e.g., per 1 ol/L boost in lycopene, mean age was six.6 years reduced (-6.638 years). years).(mol/L) 1 51.35 49.36, 53.34 Table 4. Association of carotenoids and -tocopherol with age. Lycopene -6.638 -7.778, -5.499 -0.248 0.059 Tocopherol 0.229, 0.348 Partial R 0.208 0.042 (B) 0.289 95 CI (R2 ) Carotene -5.761 -8.012, -3.524 -0.112 0.011 51.35 49.36, 53.34 ( ol/L) 1 Cryptoxanthin five.062 -7.778, -5.499 3.302, six.823 -0.248 0.125 0.011 Lycopene -6.638 0.059 2 (mol/mmol) 50.64, 55.41 -Tocopherol 0.28953.03 0.229, 0.348 0.208 0.042 -Carotene -5.761 0.112 0.011 Lycopene/Cholesterol -39.15 -8.012, -3.524 -45.64, -32.65 –0.256 0.076 -Cryptoxanthin 0.125 0.011 Tocopherol/Cholesterol 5.0621.394 three.302, six.823 1.009, 1.780 0.157 0.022 two 53.03 ( ol/mmol) Carotene/Cholesterol -36.32 50.64, 55.41 -48.68, -23.96 -0.128 0.011 Lycopene/Cholesterol -39.2,5-Dihydroxyterephthalic acid uses 15 0.Price of Dibenzyl carbonate 076 Cryptoxanthin/Cholesterol 25.PMID:23789847 85 -45.64, -32.65 16.21, 35.49 -0.256 0.117 0.0.001 0.001 0.001 p 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.Figure 1. Imply lycopene across age groups. The black line indicates the imply plasma concentration of Figure 1. Imply lycopene across age groups. The black line indicates the mean plasma concentration of lycopene in the various age groups (n = 2118). lycopene in the distinctive age groups (n = 2118).Nutrients 2016, eight, 614 Nutrients 2016, eight,9 of9 of(a)3.Age(b) Season(c) Country2.Lycopene [ ol/L] Tocopherol [ ol/L] Carotene [ ol/L] Cryptoxanthin [ ol/L]2.1.1.0.0.010 1.0.0.0.0.0 1.1.0.0.Figure two. Micronutrient concentrations by age, season, and country. Box-plots of plasma lycopene, Figure two. Micronutrient concentrations by age, season, and country. Boxplots of plasma lycopene, tocopherol, carotene, and cryptoxanthin by (a) age in fiveyear age groups; (b) season; and (c) (c) -tocopherol, -carotene, and -cryptoxanthin by (a) age in five-year age groups; (b) season; and nation (AUT, Austria; BEL, Belgium; GER, Germany; GRE, Greece; ITA, Italy; POL, Poland). Extreme country (AUT, Austria; BEL, Belgium; GER, Germany; GRE, Greece; ITA, Italy; POL, Poland). Extreme values are incorporated in analyses but not shown inside the figure. values are incorporated in analyses but not shown in the figure.Nutrients 2016, 8,10 ofCholesterol was highly and positively related to -tocopherol ( p two = 0.266; Table A1). Reduced plasma lycopene was linked to overweight and/or obesity, use of vitamin supplements, daily fruit and higher frequency in juice consumption, under no circumstances consuming French fries and seldom but additionally everyday meat servings. The frequent consumption of fruit or vegetables.